The different flavours of gene therapy for HIV cure
MODERATORS
Chantelle Ahlenstiel
Kirby Institute, Australia
Raif Derrazi
HOPE Collaboratory, United States
Share
This symposium will summarize recent advances and challenges in gene editing tools for curing HIV. Gene therapies under development seek to render target cells resistant to infection, to specifically excise or disable the integrated proviruses, or to modify immune cells to make them produce antiviral molecules (including bNAbs) in response to viral antigens or to enhance their capacity to eliminate the infected cells.
10:30
2 min
Introduction
HOPE Collaboratory, United States
Kirby Institute, Australia
10:32
10 min
CRISPR research updates
Amsterdam UMC, Netherlands, the
10:42
10 min
CRISPR clinical trial with EBT-101 for HIV (using Excision therapeutics)
Washington University, United States
10:52
10 min
Applications of engineered B cells in HIV research
Broad Institute, United States
11:02
28 min
Q&A and conclusion
HOPE Collaboratory, United States
Kirby Institute, Australia
Amsterdam UMC, Netherlands, the
Washington University, United States
Broad Institute, United States